Tang Prize Biopharmaceutical Award Winner Rosenberg: Witnessing Tumor Disappearance Inspired Immunotherapy [Interview]
NQ Score
91/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Dr. Steven A. Rosenberg, hailed as the 'father of cancer immunotherapy,' shares how observing spontaneous tumor regression in terminal cancer patients led him to pioneer TIL and CAR-T cell therapies.
AI Analysis
Frequently Asked Questions
- Q: What inspired Rosenberg's research?
- A: He observed rare cases where tumors disappeared naturally, leading him to explore immune system potential.
- Q: What is the success rate of TIL therapy?
- A: 56% of melanoma patients show tumor regression, with 25% achieving complete and durable remission.
- Q: Why are epithelial cancers hard to treat?
- A: Their tumor microenvironment suppresses immune cell infiltration and activation.